nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.206	0.356	CbGbCtD
Trisalicylate-choline—PTGS2—Etoposide—peripheral nervous system neoplasm	0.203	0.349	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—peripheral nervous system neoplasm	0.171	0.295	CbGbCtD
Trisalicylate-choline—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00126	0.003	CcSEcCtD
Trisalicylate-choline—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.003	CcSEcCtD
Trisalicylate-choline—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00297	CcSEcCtD
Trisalicylate-choline—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00291	CcSEcCtD
Trisalicylate-choline—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00282	CcSEcCtD
Trisalicylate-choline—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00281	CcSEcCtD
Trisalicylate-choline—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00279	CcSEcCtD
Trisalicylate-choline—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00274	CcSEcCtD
Trisalicylate-choline—Sweating—Vincristine—peripheral nervous system neoplasm	0.00113	0.00269	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00266	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00266	CcSEcCtD
Trisalicylate-choline—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00261	CcSEcCtD
Trisalicylate-choline—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00261	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.0026	CcSEcCtD
Trisalicylate-choline—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.0026	CcSEcCtD
Trisalicylate-choline—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00105	0.0025	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00248	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00247	CcSEcCtD
Trisalicylate-choline—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00247	CcSEcCtD
Trisalicylate-choline—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00247	CcSEcCtD
Trisalicylate-choline—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00245	CcSEcCtD
Trisalicylate-choline—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00245	CcSEcCtD
Trisalicylate-choline—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00245	CcSEcCtD
Trisalicylate-choline—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00243	CcSEcCtD
Trisalicylate-choline—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00242	CcSEcCtD
Trisalicylate-choline—Oedema—Melphalan—peripheral nervous system neoplasm	0.00101	0.00242	CcSEcCtD
Trisalicylate-choline—Shock—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00241	CcSEcCtD
Trisalicylate-choline—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00241	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.001	0.00238	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000992	0.00237	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000992	0.00237	CcSEcCtD
Trisalicylate-choline—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000986	0.00235	CcSEcCtD
Trisalicylate-choline—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000978	0.00233	CcSEcCtD
Trisalicylate-choline—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000978	0.00233	CcSEcCtD
Trisalicylate-choline—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000966	0.0023	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.000964	0.0023	CcSEcCtD
Trisalicylate-choline—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000959	0.00229	CcSEcCtD
Trisalicylate-choline—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000959	0.00229	CcSEcCtD
Trisalicylate-choline—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000953	0.00227	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.000948	0.00226	CcSEcCtD
Trisalicylate-choline—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000947	0.00226	CcSEcCtD
Trisalicylate-choline—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000912	0.00218	CcSEcCtD
Trisalicylate-choline—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000912	0.00218	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000911	0.00217	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000911	0.00217	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000903	0.00215	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000903	0.00215	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000899	0.00214	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000892	0.00213	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000892	0.00213	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000892	0.00213	CcSEcCtD
Trisalicylate-choline—Pain—Topotecan—peripheral nervous system neoplasm	0.000885	0.00211	CcSEcCtD
Trisalicylate-choline—Constipation—Topotecan—peripheral nervous system neoplasm	0.000885	0.00211	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000881	0.0021	CcSEcCtD
Trisalicylate-choline—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000878	0.00209	CcSEcCtD
Trisalicylate-choline—Pain—Tretinoin—peripheral nervous system neoplasm	0.000878	0.00209	CcSEcCtD
Trisalicylate-choline—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000878	0.00209	CcSEcCtD
Trisalicylate-choline—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000878	0.00209	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.000877	0.00209	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.000872	0.00208	CcSEcCtD
Trisalicylate-choline—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00087	0.00207	CcSEcCtD
Trisalicylate-choline—Pain—Melphalan—peripheral nervous system neoplasm	0.000866	0.00207	CcSEcCtD
Trisalicylate-choline—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000866	0.00206	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000862	0.00206	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000853	0.00203	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000846	0.00202	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000846	0.00202	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000843	0.00201	CcSEcCtD
Trisalicylate-choline—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000839	0.002	CcSEcCtD
Trisalicylate-choline—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000822	0.00196	CcSEcCtD
Trisalicylate-choline—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000815	0.00194	CcSEcCtD
Trisalicylate-choline—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000815	0.00194	CcSEcCtD
Trisalicylate-choline—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000812	0.00194	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000808	0.00193	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.000807	0.00192	CcSEcCtD
Trisalicylate-choline—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000805	0.00192	CcSEcCtD
Trisalicylate-choline—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.0008	0.00191	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000798	0.0019	CcSEcCtD
Trisalicylate-choline—Flushing—Etoposide—peripheral nervous system neoplasm	0.000793	0.00189	CcSEcCtD
Trisalicylate-choline—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00187	CcSEcCtD
Trisalicylate-choline—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000778	0.00185	CcSEcCtD
Trisalicylate-choline—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.00182	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000752	0.00179	CcSEcCtD
Trisalicylate-choline—Oedema—Vincristine—peripheral nervous system neoplasm	0.00075	0.00179	CcSEcCtD
Trisalicylate-choline—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000741	0.00177	CcSEcCtD
Trisalicylate-choline—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000732	0.00175	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000729	0.00174	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000729	0.00174	CcSEcCtD
Trisalicylate-choline—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000727	0.00173	CcSEcCtD
Trisalicylate-choline—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000726	0.00173	CcSEcCtD
Trisalicylate-choline—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000726	0.00173	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000725	0.00173	CcSEcCtD
Trisalicylate-choline—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000717	0.00171	CcSEcCtD
Trisalicylate-choline—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000717	0.00171	CcSEcCtD
Trisalicylate-choline—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000714	0.0017	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000708	0.00169	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000707	0.00168	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000702	0.00167	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000702	0.00167	CcSEcCtD
Trisalicylate-choline—Hypotension—Vincristine—peripheral nervous system neoplasm	0.0007	0.00167	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000693	0.00165	CcSEcCtD
Trisalicylate-choline—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000692	0.00165	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000691	0.00165	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000685	0.00163	CcSEcCtD
Trisalicylate-choline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000684	0.00163	CcSEcCtD
Trisalicylate-choline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000679	0.00162	CcSEcCtD
Trisalicylate-choline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000679	0.00162	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00161	CcSEcCtD
Trisalicylate-choline—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000665	0.00159	CcSEcCtD
Trisalicylate-choline—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000665	0.00159	CcSEcCtD
Trisalicylate-choline—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000663	0.00158	CcSEcCtD
Trisalicylate-choline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000658	0.00157	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.00156	CcSEcCtD
Trisalicylate-choline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000653	0.00156	CcSEcCtD
Trisalicylate-choline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000653	0.00156	CcSEcCtD
Trisalicylate-choline—Rash—Topotecan—peripheral nervous system neoplasm	0.000652	0.00156	CcSEcCtD
Trisalicylate-choline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000652	0.00155	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000652	0.00155	CcSEcCtD
Trisalicylate-choline—Headache—Topotecan—peripheral nervous system neoplasm	0.000648	0.00155	CcSEcCtD
Trisalicylate-choline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000647	0.00154	CcSEcCtD
Trisalicylate-choline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000647	0.00154	CcSEcCtD
Trisalicylate-choline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000647	0.00154	CcSEcCtD
Trisalicylate-choline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000647	0.00154	CcSEcCtD
Trisalicylate-choline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000644	0.00154	CcSEcCtD
Trisalicylate-choline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000643	0.00153	CcSEcCtD
Trisalicylate-choline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000643	0.00153	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00153	CcSEcCtD
Trisalicylate-choline—Pain—Vincristine—peripheral nervous system neoplasm	0.000641	0.00153	CcSEcCtD
Trisalicylate-choline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000641	0.00153	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000641	0.00153	CcSEcCtD
Trisalicylate-choline—Rash—Melphalan—peripheral nervous system neoplasm	0.000639	0.00152	CcSEcCtD
Trisalicylate-choline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000638	0.00152	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000632	0.00151	CcSEcCtD
Trisalicylate-choline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000632	0.00151	CcSEcCtD
Trisalicylate-choline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000619	0.00148	CcSEcCtD
Trisalicylate-choline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.00147	CcSEcCtD
Trisalicylate-choline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000615	0.00147	CcSEcCtD
Trisalicylate-choline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000612	0.00146	CcSEcCtD
Trisalicylate-choline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.00145	CcSEcCtD
Trisalicylate-choline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00061	0.00145	CcSEcCtD
Trisalicylate-choline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000602	0.00143	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000598	0.00143	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000587	0.0014	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.0014	CcSEcCtD
Trisalicylate-choline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000579	0.00138	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000576	0.00137	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000574	0.00137	CcSEcCtD
Trisalicylate-choline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000567	0.00135	CcSEcCtD
Trisalicylate-choline—Pain—Cisplatin—peripheral nervous system neoplasm	0.000567	0.00135	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00132	CcSEcCtD
Trisalicylate-choline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00131	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000546	0.0013	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000545	0.0013	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00054	0.00129	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000534	0.00127	CcSEcCtD
Trisalicylate-choline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000533	0.00127	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000532	0.00127	CcSEcCtD
Trisalicylate-choline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000529	0.00126	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000528	0.00126	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—peripheral nervous system neoplasm	0.000519	0.00124	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000519	0.00124	CcSEcCtD
Trisalicylate-choline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.00123	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000513	0.00122	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000512	0.00122	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.0012	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000503	0.0012	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.0005	0.00119	CcSEcCtD
Trisalicylate-choline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.00119	CcSEcCtD
Trisalicylate-choline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000496	0.00118	CcSEcCtD
Trisalicylate-choline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000495	0.00118	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.00118	CcSEcCtD
Trisalicylate-choline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00117	CcSEcCtD
Trisalicylate-choline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00117	CcSEcCtD
Trisalicylate-choline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.00116	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000482	0.00115	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00114	CcSEcCtD
Trisalicylate-choline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000477	0.00114	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00113	CcSEcCtD
Trisalicylate-choline—Rash—Vincristine—peripheral nervous system neoplasm	0.000473	0.00113	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000472	0.00113	CcSEcCtD
Trisalicylate-choline—Headache—Vincristine—peripheral nervous system neoplasm	0.00047	0.00112	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.00111	CcSEcCtD
Trisalicylate-choline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.0011	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000453	0.00108	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00108	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00106	CcSEcCtD
Trisalicylate-choline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000445	0.00106	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000445	0.00106	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00106	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00043	0.00102	CcSEcCtD
Trisalicylate-choline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000421	0.001	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000999	CcSEcCtD
Trisalicylate-choline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000418	0.000996	CcSEcCtD
Trisalicylate-choline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000417	0.000995	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000994	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000415	0.00099	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000985	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000981	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000974	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000402	0.000957	CcSEcCtD
Trisalicylate-choline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000394	0.000938	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000386	0.00092	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00092	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—peripheral nervous system neoplasm	0.000383	0.000913	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000382	0.000912	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—peripheral nervous system neoplasm	0.00038	0.000907	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000901	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000361	0.00086	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000818	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000811	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000798	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000784	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000773	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000758	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000757	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000751	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000739	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000726	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000721	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000716	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000714	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000705	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000702	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000694	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000694	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000669	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000667	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000661	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000653	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000645	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000642	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000642	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000619	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000596	CcSEcCtD
Trisalicylate-choline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000574	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000555	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000537	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000531	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000516	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000514	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000512	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000511	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000508	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000496	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000482	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000477	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000473	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000473	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00047	CcSEcCtD
Trisalicylate-choline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000446	CcSEcCtD
